Dr. Alex Feoktistov discussing cluster headaches at the American Academy of Pain Medicine, 2018

https://www.medcentral.com/neurology/migraine/tacs-identifying-treating-non-migrainous-headache

Author

Alexander Feoktistov MD, PhD Founder and Director of the Synergy Integrative Headache Center.

You Might Also Enjoy...

Role of magnesium in migraine treatment

Magnesium glycinate offers a promising and well-tolerated option for migraine management. Its high bioavailability and gentle effect on the digestive system make it a suitable choice for many individuals suffering from migraine.

FDA approved a new rizatriptan orally disintegrating film, Rizafilm.

FDA approves Rizafilm, the first oral thin film using IntelGenx proprietary drug delivery technology, for the acute treatment of migraine with or without aura.

FDA recently cleared Nerivio for preventive treatment of migraine

The prescription wearable neuromodulation device, Nerivio, was recently cleared by the FDA for preventive treatment of migraine.

Recently FDA approved nasal spray for acute migraine treatment is coming to market.

FDA has approved a new nasal spray for acute treatment of migraine in adults.

Adolescent Migraine: Q & A with Dr. Feoktistov and Migraine.com

A brief discussion about a balanced approach to migraine treatment that may include lifestyle modifications, medications, and the state-of-the-art approved neuromodulation devices that may help treat and prevent migraine attacks.

Advanced option in migraine management

Dr. Alex's interview with MassDevice medical network about novel options in migraine management: CGRP active drugs and non-invasive neuromodulation devices approved for migraine treatment.